Skip to main content
Clinical Trials/ITMCTR2200006455
ITMCTR2200006455
Not yet recruiting
Phase 1

Preliminary study on analgesic and sedative effects of percutaneous acupoint electrical stimulation in vertebroplasty in OVCF patients

Wangjing Hospital, China Academy of Chinese Medical Sciences0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
osteoporotic vertebral compression fracture
Sponsor
Wangjing Hospital, China Academy of Chinese Medical Sciences
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Wangjing Hospital, China Academy of Chinese Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • (1\) Meet the diagnostic criteria of OVCF and t9\-l5 single segment percutaneous vertebroplasty;
  • (2\) Age 60 to 80 years old;
  • (3\) ASA class I\-II;
  • (4\)18kg/m 2 \< BMI \< 30kg/m 2
  • (5\)Voluntarily participate in this clinical study and sign the informed consent form.

Exclusion Criteria

  • (1\) Taking sedative and analgesic drugs, or taking drugs or drinking alcohol within 48 hours before operation;
  • (2\) Communication disorders, including language disorders, previous nervous system diseases and mental disorders;
  • (3\) Those who have contraindications to transcutaneous electrical stimulation, including those who stimulate local skin damage or infection, have implants in the body
  • Sexual electrophysiological device;
  • (4\) Allergic to narcotic drugs;
  • (5\) Severe heart, liver, kidney and other organ dysfunction, blood system and autoimmune diseases, acute and slow sex appeal
  • Infected, malignant tumor or serious mental disease;
  • (6\)Unable to cooperate with the researcher to complete this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials